The influence of non-HLA gene polymorphisms and interactions on disease risk in a Western Australian multiple sclerosis cohort

Journal of Neuroimmunology

Volumn 261, Issue 1-2, 2013, Pages 92-97

  Qiu, Wei ^a,b,c,d   Pham, Kym ^b,c,d   James, Ian ^e,f   Nolan, David ^f   Castley, Allison ^f   Christiansen, Frank T ^b,f   Czarniak, Petra ^g   Luo, Yuebei ^b,c,d   Wu, Jingshan ^b,c,d   Garlepp, Michael ^g   Wilton, Steve ^b,c,d   Carroll, William M ^b,c,d   Mastaglia, Frank L ^b,c,d   Kermode, Allan G ^b,c,d,e  

^a THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^d PATHWEST LABORATORY MEDICINE   (Australia)

^e MURDOCH UNIVERSITY   (Australia)

^f ROYAL PERTH HOSPITAL   (Australia)

^g CURTIN UNIVERSITY   (Australia)

Author keywords

APOE; CLEC 16A; CTLA 4; HLA; ICAM 1; IL2RA; IL7R; IRF5; Multiple sclerosis; Non HLA genes; Single nucleotide polymorphisms; STAT3; TYK2

Indexed keywords

APOLIPOPROTEIN E; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON REGULATORY FACTOR 5; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; PROTEIN KINASE TYK2; STAT3 PROTEIN;

ADULT; APOLIPOPROTEIN E GENE; ARTICLE; AUSTRALIA; C TYPE LECTIN DOMAIN FAMILY 16 GENE; CD58 GENE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 GENE; EPISTASIS; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; INTERCELLULAR ADHESION MOLECULE 1 GENE; INTERFERON REGULATORY FACTOR 5 GENE; INTERLEUKIN 2 RECEPTOR A GENE; INTERLEUKIN 7 RECEPTOR GENE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TYROSINE KINASE 2 GENE;

APOE; APOLIPOPROTEIN E; C-TYPE LECTIN DOMAIN FAMILY 16; CLEC-16A; CTLA-4; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; HLA; ICAM-1; IL2RA; IL7R; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON REGULATORY FACTOR 5; INTERLEUKIN 2 RECEPTOR A; INTERLEUKIN 7 RECEPTOR; IRF5; MULTIPLE SCLEROSIS; NON-HLA GENES; SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3; SINGLE NUCLEOTIDE POLYMORPHISMS; STAT3; TYK2; TYROSINE KINASE 2;

ADULT; COHORT STUDIES; FEMALE; HLA ANTIGENS; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; REGISTRIES; RISK FACTORS; WESTERN AUSTRALIA;

EID: 84880821044     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2013.04.022     Document Type: Article

References (39)

1. ANZgene Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat. Genet. 2009, 41:824-828.
2. Ban M., Goris A., Lorentzen A.R., Baker A., Mihalova T., Ingram G., Booth D.R., Heard R.N., Stewart G.J., Bogaert E., Dubois B., Harbo H.F., Celius E.G., Spurkland A., Strange R., Hawkins C., Robertson N.P., Dudbridge F., Wason J., De Jager P.L., Hafler D., Rioux J.D., Ivinson A.J., McCauley J.L., Pericak-Vance M., Oksenberg J.R., Hauser S.L., Sexton D., Haines J., Sawcer S. Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor. Eur. J. Hum. Genet. 2009, 17:1309-1313.
3. Baranzini S.E., Wang J., Gibson R.A., Galwey N., Naegelin Y., Barkhof F., Radue E.W., Lindberg R.L., Uitdehaag B.M., Johnson M.R., Angelakopoulou A., Hall L., Richardson J.C., Prinjha R.K., Gass A., Geurts J.J., Kragt J., Sombekke M., Vrenken H., Qualley P., Lincoln R.R., Gomez R., Caillier S.J., George M.F., Mousavi H., Guerrero R., Okuda D.T., Cree B.A., Green A.J., Waubant E., Goodin D.S., Pelletier D., Matthews P.M., Hauser S.L., Kappos L., Polman C.H., Oksenberg J.R. Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum. Mol. Genet. 2009, 18:767-778.
4. Burwick R.M., Ramsay P.P., Haines J.L., Hauser S.L., Oksenberg J.R., Pericak-Vance M.A., Schmidt S., Compston A., Sawcer S., Cittadella R., Savettieri G., Quattrone A., Polman C.H., Uitdehaag B.M., Zwemmer J.N., Hawkins C.P., Ollier W.E., Weatherby S., Enzinger C., Fazekas F., Schmidt H., Schmidt R., Hillert J., Masterman T., Hogh P., Niino M., Kikuchi S., Maciel P., Santos M., Rio M.E., Kwiecinski H., Zakrzewska-Pniewska B., Evangelou N., Palace J., Barcellos L.F. APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers. Neurology 2006, 66:1373-1383.
5. Cenit M.C., Alcina A., Marquez A., Mendoza J.L., Diaz-Rubio M., de las Heras V., Izquierdo G., Arroyo R., Fernandez O., de la Concha E.G., Matesanz F., Urcelay E. STAT3 locus in inflammatory bowel disease and multiple sclerosis susceptibility. Genes Immun. 2010, 11:264-268.
6. Cournu-Rebeix I., Genin E., Lesca G., Azoulay-Cayla A., Tubridy N., Noe E., Clanet M., Edan G., Clerget-Darpoux F., Semana G., Fontaine B. Intercellular adhesion molecule-1: a protective haplotype against multiple sclerosis. Genes Immun. 2003, 4:518-523.
7. De Jager P.L., Baecher-Allan C., Maier L.M., Arthur A.T., Ottoboni L., Barcellos L., McCauley J.L., Sawcer S., Goris A., Saarela J., Yelensky R., Price A., Leppa V., Patterson N., de Bakker P.I., Tran D., Aubin C., Pobywajlo S., Rossin E., Hu X., Ashley C.W., Choy E., Rioux J.D., Pericak-Vance M.A., Ivinson A., Booth D.R., Stewart G.J., Palotie A., Peltonen L., Dubois B., Haines J.L., Weiner H.L., Compston A., Hauser S.L., Daly M.J., Reich D., Oksenberg J.R., Hafler D.A. The role of the CD58 locus in multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:5264-5269.
8. Dyment D.A., Cader M.Z., Chao M.J., Lincoln M.R., Morrison K.M., Disanto G., Morahan J.M., De Luca G.C., Sadovnick A.D., Lepage P., Montpetit A., Ebers G.C., Ramagopalan S.V. Exome sequencing identifies a novel multiple sclerosis susceptibility variant in the TYK2 gene. Neurology 2012, 79:406-411.
9. Fang L., Isobe N., Yoshimura S., Yonekawa T., Matsushita T., Masaki K., Doi H., Ochi K., Miyamoto K., Kawano Y., Kira J. Interleukin-7 receptor alpha gene polymorphism influences multiple sclerosis risk in Asians. Neurology 2011, 76:2125-2127.
10. Gregory S.G., Schmidt S., Seth P., Oksenberg J.R., Hart J., Prokop A., Caillier S.J., Ban M., Goris A., Barcellos L.F., Lincoln R., McCauley J.L., Sawcer S.J., Compston D.A., Dubois B., Hauser S.L., Garcia-Blanco M.A., Pericak-Vance M.A., Haines J.L. Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat. Genet. 2007, 39:1083-1091.
11. Hafler D.A., Compston A., Sawcer S., Lander E.S., Daly M.J., De Jager P.L., de Bakker P.I., Gabriel S.B., Mirel D.B., Ivinson A.J., Pericak-Vance M.A., Gregory S.G., Rioux J.D., McCauley J.L., Haines J.L., Barcellos L.F., Cree B., Oksenberg J.R., Hauser S.L. Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med. 2007, 357:851-862.
12. Hoppenbrouwers I.A., Aulchenko Y.S., Janssens A.C., Ramagopalan S.V., Broer L., Kayser M., Ebers G.C., Oostra B.A., van Duijn C.M., Hintzen R.Q. Replication of CD58 and CLEC16A as genome-wide significant risk genes for multiple sclerosis. J. Hum. Genet. 2009, 54:676-680.
13. Huang Y., Weisgraber K.H., Mucke L., Mahley R.W. Apolipoprotein E: diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer's disease. J. Mol. Neurosci. 2004, 23:189-204.
14. IMSGC Refining genetic associations in multiple sclerosis. Lancet Neurol. 2008, 7:567-569.
15. IMSGC The expanding genetic overlap between multiple sclerosis and type I diabetes. Genes Immun. 2009, 10:11-14.
16. Irizar H., Munoz-Culla M., Zuriarrain O., Goyenechea E., Castillo-Trivino T., Prada A., Saenz-Cuesta M., De Juan D., Lopez de Munain A., Olascoaga J., Otaegui D. HLA-DRB1*15:01 and multiple sclerosis: a female association?. Mult. Scler. 2011, 18:569-577.
17. Jakkula E., Leppa V., Sulonen A.M., Varilo T., Kallio S., Kemppinen A., Purcell S., Koivisto K., Tienari P., Sumelahti M.L., Elovaara I., Pirttila T., Reunanen M., Aromaa A., Oturai A.B., Sondergaard H.B., Harbo H.F., Mero I.L., Gabriel S.B., Mirel D.B., Hauser S.L., Kappos L., Polman C., De Jager P.L., Hafler D.A., Daly M.J., Palotie A., Saarela J., Peltonen L. Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene. Am. J. Hum. Genet. 2010, 86:285-291.
18. Kristjansdottir G., Sandling J.K., Bonetti A., Roos I.M., Milani L., Wang C., Gustafsdottir S.M., Sigurdsson S., Lundmark A., Tienari P.J., Koivisto K., Elovaara I., Pirttila T., Reunanen M., Peltonen L., Saarela J., Hillert J., Olsson T., Landegren U., Alcina A., Fernandez O., Leyva L., Guerrero M., Lucas M., Izquierdo G., Matesanz F., Syvanen A.C. Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations. J. Med. Genet. 2008, 45:362-369.
19. Lill C.M., Liu T., Schjeide B.M., Roehr J.T., Akkad D.A., Damotte V., Alcina A., Ortiz M.A., Arroyo R., Lopez de Lapuente A., Blaschke P., Winkelmann A., Gerdes L.A., Luessi F., Fernadez O., Izquierdo G., Antiguedad A., Hoffjan S., Cournu-Rebeix I., Gromoller S., Faber H., Liebsch M., Meissner E., Chanvillard C., Touze E., Pico F., Corcia P., Dorner T., Steinhagen-Thiessen E., Baeckman L., Heekeren H.R., Li S.C., Lindenberger U., Chan A., Hartung H.P., Aktas O., Lohse P., Kumpfel T., Kubisch C., Epplen J.T., Zettl U.K., Fontaine B., Vandenbroeck K., Matesanz F., Urcelay E., Bertram L., Zipp F. Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects. J. Med. Genet. 2012, 49:558-562.
20. + T cells prevents development of experimental autoimmune diseases. J. Immunol. 2008, 180:6070-6076.
21. Lundmark F., Duvefelt K., Iacobaeus E., Kockum I., Wallstrom E., Khademi M., Oturai A., Ryder L.P., Saarela J., Harbo H.F., Celius E.G., Salter H., Olsson T., Hillert J. Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat. Genet. 2007, 39:1108-1113.
22. Mahley R.W., Weisgraber K.H., Huang Y. Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS. J. Lipid Res. 2009, 50:S183-S188. (Suppl.).
23. McCoy K.D., Le Gros G. The role of CTLA-4 in the regulation of T cell immune responses. Immunol. Cell Biol. 1999, 77:1-10.
24. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F.D., McFarland H.F., Paty D.W., Polman C.H., Reingold S.C., Sandberg-Wollheim M., Sibley W., Thompson A., van den Noort S., Weinshenker B.Y., Wolinsky J.S. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 2001, 50:121-127.
25. Mero I.L., Lorentzen A.R., Ban M., Smestad C., Celius E.G., Aarseth J.H., Myhr K.M., Link J., Hillert J., Olsson T., Kockum I., Masterman T., Oturai A.B., Sondergaard H.B., Sellebjerg F., Saarela J., Kemppinen A., Elovaara I., Spurkland A., Dudbridge F., Lie B.A., Harbo H.F. A rare variant of the TYK2 gene is confirmed to be associated with multiple sclerosis. Eur. J. Hum. Genet. 2010, 18:502-504.
26. Mycko M.P., Kwinkowski M., Tronczynska E., Szymanska B., Selmaj K.W. Multiple sclerosis: the increased frequency of the ICAM-1 exon 6 gene point mutation genetic type K469. Ann. Neurol. 1998, 44:70-75.
27. Nejentsev S., Laaksonen M., Tienari P.J., Fernandez O., Cordell H., Ruutiainen J., Wikstrom J., Pastinen T., Kuokkanen S., Hillert J., Ilonen J. Intercellular adhesion molecule-1 K469E polymorphism: study of association with multiple sclerosis. Hum. Immunol. 2003, 64:345-349.
28. O'Doherty C., Kantarci O., Vandenbroeck K. IL7RA polymorphisms and susceptibility to multiple sclerosis. N. Engl. J. Med. 2008, 358:753-754.
29. Pandit L., Ban M., Sawcer S., Singhal B., Nair S., Radhakrishnan K., Shetty R., Misri Z., Hegde S., Bhat I.G. Evaluation of the established non-MHC multiple sclerosis loci in an Indian population. Mult. Scler. 2011, 17:139-143.
30. Perera D., Stankovich J., Butzkueven H., Taylor B.V., Foote S.J., Kilpatrick T.J., Rubio J.P. Fine mapping of multiple sclerosis susceptibility genes provides evidence of allelic heterogeneity at the IL2RA locus. J. Neuroimmunol. 2009, 211:105-109.
31. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., Tourtellotte W.W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 1983, 13:227-231.
32. Rubio J.P., Stankovich J., Field J., Tubridy N., Marriott M., Chapman C., Bahlo M., Perera D., Johnson L.J., Tait B.D., Varney M.D., Speed T.P., Taylor B.V., Foote S.J., Butzkueven H., Kilpatrick T.J. Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians. Genes Immun. 2008, 9:624-630.
33. Sayer D., Whidborne R., Brestovac B., Trimboli F., Witt C., Christiansen F. HLA-DRB1 DNA sequencing based typing: an approach suitable for high throughput typing including unrelated bone marrow registry donors. Tissue Antigens 2001, 57:46-54.
34. Steiner O., Coisne C., Cecchelli R., Boscacci R., Deutsch U., Engelhardt B., Lyck R. Differential roles for endothelial ICAM-1, ICAM-2, and VCAM-1 in shear-resistant T cell arrest, polarization, and directed crawling on blood-brain barrier endothelium. J. Immunol. 2010, 185:4846-4855.
35. van der Walt A., Stankovich J., Bahlo M., Taylor B.V., van der Mei I.A., Foote S.J., Kilpatrick T.J., Rubio J.P., Butzkueven H. Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy. Neurology 2009, 73:1018-1025.
36. Verghese P.B., Castellano J.M., Holtzman D.M. Apolipoprotein E in Alzheimer's disease and other neurological disorders. Lancet Neurol. 2011, 10:241-252.
37. WTCCC Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011, 476:214-219.
38. Wu J.S., James I., Qiu W., Castley A., Christiansen F.T., Carroll W.M., Mastaglia F.L., Kermode A.G. HLA-DRB1 allele heterogeneity influences multiple sclerosis severity as well as risk in Western Australia. J. Neuroimmunol. 2010, 219:109-113.
39. Zhang Z., Duvefelt K., Svensson F., Masterman T., Jonasdottir G., Salter H., Emahazion T., Hellgren D., Falk G., Olsson T., Hillert J., Anvret M. Two genes encoding immune-regulatory molecules (LAG3 and IL7R) confer susceptibility to multiple sclerosis. Genes Immun. 2005, 6:145-152.